Abstract
Based on the successfully held of 7TH ICABST–
As an annual gathering, it provides an extensive platform for scientists, researchers and scholars to present their research results and newest findings in all fields of Biological Science and Technology, especially in Biotechnology and Bioengineering, Bioinformatics, Biomedical Engineering, Clinical Medicine, Animal and Plant Sciences and other related topics, discuss the practical challenges encountered recommend better solutions for biotechnology and biomedicine. ICABST will include keynote speeches, invited speeches, oral presentations and poster presentations. The conference certification will be issued to all attendees including listeners.
Besides, the ICABST workshops “International Workshop on Nursing and Clinical Research (WNCR)” and “International Workshop on Pharmaceutical and Clinical Research (WPCR)” will be held simultaneously with the ICABST.
Scientific Committee
Andrea Scribante, University of Pavia, Italy
Anna Ardévol, Universitat Rovira i Virgili, Spain
Chen Xiong, Taihe Hospital Affiliated to Hubei University of Medicine, China
Ching-An Peng, University of Idaho, USA
Christophis Koroneos, University of Western Macedonia, Greece
Dinh-Toi Chu, Hanoi National University of Education, Vietnam
Domenico Lombardo, CNR - (Consiglio Nazionale delle Ricerche), Italy
Farhad Memarzadeh, National Institutes of Health, USA
Gary Sweeney, York University, Canada
Gerrit Schüürmann, Technical University Bergakademie Freiberg, Germany
Gohar Mushtaq, King Abdulaziz University, Saudi Arabia
Jason Guowei Sun, Asia-Pacific Association of Natural Science and Engeineering, China
Khalid Rehman Hakeem, Universiti Putra, Malaysia
KIKUCHI Masumi, University of Tokyo, Japan
Muhammad Asad Ali, University of Veterinary and Animal Sciences, Pakistan
Nagendra Kumar Kaushik, Kwangwoon University, Korea
Pornpun Vivithanaporn, Mahidol University, Thailand
Suhaimi Suratman, Institute of Oceanography and Environment, Malaysia
Thi Thuy Pham, VNU-University of Science, Vietnam
Review Committee
Agnès Drochon, National Center for Scientific Research, France
Ahmad Zahedi, James Cook University, Australia
Ahmed Saber Abu-zaiton, Al-albayt University, Jordan
AMAL AL-ABOUDI, University of Jordan, Jordan
Ayush Dogra, Panjab University, India
Ivaylo Christov, Institute of Biophysics and Biomedical Engineering, Bulgaria
Kesaven Bhubalan, Universiti Malaysia Terengganu, Malaysia
Le Nguyen Quoc Khanh, Nanyang Technological University, Singapore
Leyser Rodrigues Oliveira University Centre of Formiga, Brazil
Mazhar Ul Islam, College of Engineering, Dhofar University, Oman
Midhat Nabil Ahmad Salimi, Universiti Malaysia Perlis (UniMAP), Malaysia
Mohsen Hamzeh, Amirkabir University of Technology, Iran Pajaree Thongsanit, Naresuan University, Thailand
Palanisamy Sivanandy, International Medical University (IMU), Malaysia
Reshma Rani, Amity University, India
Roshni Paul, Birmingham City University, UK
Sri Darmawati, Universitas Muhammadiyah Semarang, Indonesia
Stalis Norma Ethica, Universitas Muhammadiyah Semarang, Indonesia
Table of Contents
Introduction of 2025 International Conference on Advances in Biological Science and Technology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Based on the “Phlegm Toxicity” Theory for Brucine on the Microenvironment of Cancer Bone Metastasis of breast cancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Platinum nanoclusters combined with gefitinib inhibits non-small cell lung cancer metastasis and reverses platinum resistance by inhibiting EMT pathway and promoting DNA damage. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Application of Aspergillus-specific antibody IgG test for pulmonary aspergillosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Biomarker-Based Strategy for Discontinuation of Antiviral Therapy in HBV-Related Liver Transplant Recipients. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Protective Effects of Yangyin Qingfei Decoction on Lung Tissue Damage in Pneumonia Rats Based on Antioxidative Mechanisms. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Analysis of Risk Factors for Pulmonary complications caused by Status epilepticus. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Case Report of an 81-Year-Old Male with Eosinophilic Pleural Effusion and Chronic Pulmonary Conditions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
The Impact of Catheter to Vein Ratio on Venous Thromboembolism Incidence in Oncology Patients. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
To analyze the value of gastric contrast-enhanced ultrasound and MRI in preoperative TNM staging of advanced gastric cancer based on Kappa test. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
A study of the effect of candesartan ester on the chemotherapeutic drugs 5-Fu and OX in combination Neurodegenerative Diseases with Tumours. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Effects of nuclear transporter β1 on the biological characteristics of ovarian cancer cells by regulating the Wntβ-catenin signaling pathway. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Liquid Biopsy Analysis of Circulating [Specific RNA/DNA] Isoforms for Early Detection of Malignant Transformation of [Cancer Type]. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Thunder-fire moxibustion protects Rats against diabetic peripheral neuropathy via modulation of TLR4/ NF-κB signaling pathway. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Carbon Monoxide-Induced Myocardial Injury: Pathophysiological Mechanisms, Biomarkers, and Emerging Therapeutic Targets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Molecular classification and personalized treatment plan for triple-negative breast cancer based on multi-omics technology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Evaluation of trimetazidine combined with PCI based on color Doppler ultrasound. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Application of next-generation sequencing technology in identification of pathogens of infectious diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
New progress in the analysis of infectious pathogens and the diagnostic and identification value of next-generation sequencing technology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Research on Medical Image Segmentation Based on Convolutional Neural Networks. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Nutritional risk screening and risk factors of malnutrition in patients with acute stroke. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Progress in Personalized Treatment and Biomaterials Application of 3D Printing Technology in High tibial osteotomy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Changes in Serum Uric Acid, 25-Hydroxyvitamin D3, And Sex Hormone-Binding Globulin Levels in Patients with Type 2 Diabetes and Metabolic Syndrome and Their Clinical Significance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Effects of mental health-oriented nursing on depressive symptoms, stress coping ability and self-esteem in patients with esophageal cancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Preparation of Liquid-Crystal Polymer Materials for Near-Body Temperature Phase-Change Artificial Lenses with Enhanced Biomedical Compatibility. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Research on Political Game and Governance Coordination in Global Major Infectious Disease Prevention and Control. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Analysis of the impact of evidence-based nursing in enteral nutrition care for critically ill Patients on infection Control effect. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Potential Implications of Dietary Gelsemium elegans Benth. Extract on Growth, Gut Health and Microbiota of Yellow-feathered Chickens: A Reference Model for Human Drug Use. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16